EP2986325

Aðferðir til meðhöndlunar á þvagefnishringsröskunum

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    14.10.2014
  • EP published:
    26.6.2019
  • EP application number:
    14854074.3
  • Max expiry date:
    13.10.2034
  • Expiry date:
    13.10.2026
  • Next due date:
    31.10.2026
  • Title:
    METHODS OF TREATING UREA CYCLE DISORDERS

Timeline

Today
14.10.2014EP application
26.6.2019EP Publication
9.9.2019Translation submitted
15.10.2019Registration published
13.10.2026Expires

Owner

  • Name:
    Immedica Pharma AB
  • Address:
    Norrtullsgatan 15, 113 29 Stockholm, SE

Inventor

  • Name:
    MOKHTARANI, Masoud
  • Address:
    Walnut Creek, CA, US
  • Name:
    SCHARSCHMIDT, Bruce
  • Address:
    San Francisco, CA, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201361890827 P
  • Date:
    14.10.2013
  • Country:
    US
  • Number:
    201462044168 P
  • Date:
    29.8.2014
  • Country:
    US

Classification

  • Categories:
    A61K 31/235, A61K 31/192, G01N 33/68, G01N 33/50

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 16.9.2019

Expires: 13.10.2020

Payer: Árnason Faktor

Number: 7

Paid: 24.9.2020

Expires: 13.10.2021

Payer: Zacco Denmark A/S

Number: 8

Paid: 31.8.2021

Expires: 13.10.2022

Payer: Zacco Denmark A/S

Number: 9

Paid: 7.9.2022

Expires: 13.10.2023

Payer: Zacco Denmark A/S

Number: 10

Paid: 7.9.2023

Expires: 13.10.2024

Payer: Zacco Denmark A/S

Number: 11

Paid: 24.9.2024

Expires: 13.10.2025

Payer: Zacco Denmark A/S

Number: 12

Paid: 22.10.2025

Expires: 13.10.2026

Payer: Árnason Faktor ehf.

Upload documents